Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation

15 Dec 2011

Abstract excerpt

Dannis G. van Vuurden 1 , Esther Hulleman 1 , Olga L.M. Meijer 1 , Laurine E. Wedekind 1 , Marcel Kool 2 , Hendrik Witt 2,3 , W. Peter Vandertop 4 , Thomas Würdinger 4,5 , David P. Noske 4 , Gertjan J.L. Kaspers 6 and Jacqueline Cloos 6,7 1 Department of Pediatric Oncology / Hematology, Neuro-oncology Research Group, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, the Netherlands 2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA Repair Mechanisms
Share to Integrated Circuits and Semiconductor Failure Analysis
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22184287
DOI: 10.18632/oncotarget.362

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiationPMID 22184287Read ↗

Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of MedulloblastomaSemantic proximity Read ↗

PARP Inhibitors in Glioma: A Review of Therapeutic OpportunitiesSemantic proximity Read ↗

Therapeutic Application of PARP Inhibitors in Neuro-Oncology.Semantic proximity Read ↗

Combinations of PARP Inhibitors with Temozolomide Drive PARP1 Trapping and Apoptosis in Ewing’s SarcomaSemantic proximity Read ↗

Pediatric glioblastoma - unlike normal cells - are sensitive to the combination of vorinostat and olaparib and to its downstream effector - phosphorylated eIF2αSemantic proximity Read ↗

Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP InhibitorsSemantic proximity Read ↗

ATM inhibition enhances the efficacy of radiation across distinct molecular subgroups of pediatric high-grade gliomaSemantic proximity Read ↗

The Study on the Expression Level of PARP-1 in Glioma and Computational Screening of PARP-1 InhibitorsSemantic proximity Read ↗

Initial testing (stage 1) of the PARP inhibitor BMN 673 by the pediatric preclinical testing program: PALB2 mutation predicts exceptional in vivo response to BMN 673.Semantic proximity Read ↗

PARP Inhibitors for Sensitization of Alkylation Chemotherapy in Glioblastoma: Impact of Blood-Brain Barrier and Molecular HeterogeneitySemantic proximity Read ↗

Sensitizing Ewing sarcoma to chemo- and radiotherapy by inhibition of the DNA-repair enzymes DNA protein kinase (DNA-PK) and poly-ADP-ribose polymerase (PARP) 1/2Semantic proximity Read ↗

Olaparib: A Chemosensitizer for the Treatment of GlioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.